Abstract: A solid-state imaging device according to an embodiment includes: pixel circuits, each of the pixel circuits including: a generation unit (31) generating a voltage corresponding to a logarithmic value of a photocurrent; a capacitor (C1) having a first electrode to which the voltage generated by the generation unit is applied; a first amplifier (40a) having a first input terminal, which is connected to a second electrode of the capacitor, and a second input terminal, to which a first reference voltage (VbA0) is applied to, to output a comparison result obtained by comparing the voltage applied to the first input terminal with the voltage applied to the second input terminal; a switch unit (43) controlling a connection between the output of the first amplifier and the first input terminal; and a second amplifier (40b) having a third input terminal, to which the output of the first amplifier is connected, and a fourth input terminal, to which a second reference voltage (VbA1) is applied, to output a comparison r

Abstract: The present technology relates to an image sensor capable of suppressing the power consumption, and an electronic device. A reference signal output unit outputs a reference signal of which a level is changed and includes a plurality of DACs and a load resistance for outputting the reference signal. The plurality of DACs includes a plurality of current sources and a plurality of switches controlling a current flowing from the current source. The reference signal output unit is connected to three or more power sources, and in combinations of two power sources in the three or more power sources, each of two or more types of combinations of the power sources includes a first path through which the current controlled by the switch flows, and a second path through which a current in the same direction flows to the load resistance.

Abstract: The present technology relates to an image sensor capable of suppressing the power consumption, and an electronic device. A reference signal output unit configured to output a reference signal of which a level is changed, includes a plurality of DACs including a plurality of current sources, and a plurality of switches controlling a current flowing from the current source, and a load resistance for outputting the reference signal. Further, the reference signal output unit is connected to three or more power sources, and in combinations of two power sources in the three or more power sources, each of two or more types of combinations of the power sources includes a first path through which the current controlled by the switch, flows, and a second path through which a current in the same direction, flows to the load resistance. The present technology, for example, can be applied to an image sensor or the like, performing reference signal comparison type AD conversion.

Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

Abstract: Novel sugar-coated pharmaceutical composition such as tablets, pills, granules or the like, which contains pullulan in the sugar layer for the purpose of preventing brownish color change of the composition with lapse of time, and a method for preparing the composition.

Abstract: Novel 1-ethyl-6-fluoro-1,4-dihyono-4-oxo -7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid.sesquihydrate (ATT-2266.sesquihydrate). The aforesaid compound can be prepared by heating 1-ethyl-6-fluoro-1,4-dihydro-4-oxo -7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid at a temperature above about 60.degree. C. in the presence of water in an amount sufficient to form the sesquihydrate. This sesquihydrate is much more stable than the anhydrate and the trihydrate and is superior to the anhydrate in the rate of dissolution and transference into the body through the intestines. Thus, it is especially useful as a pharmaceutical compound.